Indication
Chronic Kidney Disease with Anemia
1 clinical trial
2 products
Product
roxadustatClinical trial
A Phase 3, Multi-center, Randomized, 2-arm Parallel, Double-blind, Active-comparator (Darbepoetin Alfa) Conversion Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With AnemiaStatus: Completed, Estimated PCD: 2018-03-13
Product
Darbepoetin alfa